HOME > MARKETS > MARKET COMMENTARY
  MARKET COMMENTARY
EQUITY
Dr. Reddy's trades in green on the bourses
Jan-09-2025

Dr. Reddy's Laboratories is currently trading at Rs. 1377.40, up by 6.80 points or 0.50% from its previous closing of Rs. 1370.60 on the BSE.

The scrip opened at Rs. 1381.00 and has touched a high and low of Rs. 1382.50 and Rs. 1364.45 respectively. So far 14627 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1420.20 on 21-Aug-2024 and a 52 week low of Rs. 1104.69 on 18-Jan-2024.

Last one week high and low of the scrip stood at Rs. 1404.60 and Rs. 1333.25 respectively. The current market cap of the company is Rs. 114933.56 crore.

The promoters holding in the company stood at 26.64%, while Institutions and Non-Institutions held 49.01% and 10.13% respectively.

Dr. Reddy's Laboratories’ wholly owned subsidiary -- Dr. Reddy’s Laboratories Inc, USA has entered into an agreement for sale of all the issued and outstanding membership interests in its wholly owned subsidiary --Dr. Reddy’s Laboratories Louisiana LLC (DRLL), along with manufacturing facility of DRLL in Shreveport, Louisiana, USA.
Consequently, Dr. Reddy’s Laboratories Louisiana LLC will cease to be a wholly owned subsidiary of Dr. Reddy’s Laboratories Inc as well as step down wholly owned subsidiary of the Dr. Reddy’s Laboratories.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


  RELATED NEWS >>